Keywords: genentech, lucentis, gets, fda, approval, use, treatment

Genentech's Lucentis gets FDA approval for use in the treatment of wet AMD

Article | 10 July 2006

Print This

US biotechnology firm Genentech says that the Food and Drug Administration has approved Lucentis (ranibizumab injection) for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in